The relationship between high Mediterranean dietary pattern (MDP) adherence and decreased low-grade systemic inflammation.
Silo Pharma Signs Agreement to Develop First-in-Class Ketamine Implant Therapeutic | Psychedelic Invest
Silo Pharma, Inc. (Nasdaq: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced its entry into a research and